Featured Research

from universities, journals, and other organizations

Race, Family History Or Baseline PSA: Which Best Predicts Prostate Cancer Risk?

Date:
May 15, 2008
Source:
American Urological Association
Summary:
African-American men with family histories of prostate cancer could benefit from a baseline prostate-specific antigen (PSA) reading to determine their probability of developing the disease.

African-American men with family histories of prostate cancer could benefit from a baseline prostate-specific antigen (PSA) reading to determine their probability of developing the disease. Researchers from Northwestern University in Chicago say this new perspective on testing could lead to highly individualized screening protocols based on a man’s baseline level and how it relates to established age-specific medians.

According to new data presented recently during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando, African-American men with known prostate cancer risk factors with baseline levels higher than the age-specific median are more likely to develop the disease in their lifetimes than the general population. However, African-American men with a family history were unlikely to develop prostate cancer if their baseline PSA level was below the age-specific median.

The effect of the baseline PSA level on future prostate cancer risk was so robust that the correlation held true even for men with other significant risk factors.

Using a study cohort drawn from a longitudinal screening study enrolling more than 26,000 volunteers between 1991 and 2001, researchers analyzed a group of 329 African-American men with a family history of prostate cancer. The volunteers were divided into three groups by ages: 40s, 50s and 60+ with a mean follow-up time of 19.5, 71 and 81 months, respectively. None of the men in their 40s or 50s with both risk factors and a baseline PSA below the median were diagnosed with prostate cancer.

Eight percent of men in their 40s with both risk factors and a PSA above the median were diagnosed, as were 16 percent of men in their 50s. Twice as many men in their 60s with both risk factors and a baseline PSA above the median were diagnosed with prostate cancer.


Story Source:

The above story is based on materials provided by American Urological Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mondo DM, Roehl KA, Loeb S, Gashti SN, Griffin CR, Smith ND et al: Which is the most important risk factor for prostate cancer: race, family history, or baseline PSA level? J Urol, suppl., 2008; 179: 148, abstract 417. [link]

Cite This Page:

American Urological Association. "Race, Family History Or Baseline PSA: Which Best Predicts Prostate Cancer Risk?." ScienceDaily. ScienceDaily, 15 May 2008. <www.sciencedaily.com/releases/2008/05/080515072912.htm>.
American Urological Association. (2008, May 15). Race, Family History Or Baseline PSA: Which Best Predicts Prostate Cancer Risk?. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2008/05/080515072912.htm
American Urological Association. "Race, Family History Or Baseline PSA: Which Best Predicts Prostate Cancer Risk?." ScienceDaily. www.sciencedaily.com/releases/2008/05/080515072912.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins